Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information INDEX abducens nerve (CN VI), 5 Acyclovir, 117 adalimumab (Humira®), 129 admission orders, 3 alefacept (Amevive®), 129–130 anesthesia. See local anesthesia; topical anesthesia angioedema, 71–72 angioid streaks (“EIC Shop), 205 antibacterials. See systemic antibacterials antibiotic prophylaxis antibiotics, 44 indications, 44 indications (AHA guidelines), 43 risk factors, 43 anticoagulants and mechanisms, 46 antigens in dermatologic diseases, 152–153 in paraneoplastic pemphigus, 153 antihistamines, 137 antimalarial agents, 127–128 antimicrobials. See topical antimicrobials antinuclear antibodies, 82 antibody, 82 disorder, 82 pattern, 82 target, 82 antiseptic cleaners, 30 antivirals. See systemic antivirals anti-Xa (unfractionated heparin anti-Xa; LMWH anti-Xa), 48 arteries, facial, 16–17 autosomal dominant diseases, 174–175 disease, 174–175 gene, 174–175 autosomal recessive diseases, 176–177 disease, 176–177 gene, 176–177 azathioprine (Imuran), 122–123 Azithromycin (macrolide [azalide]), 107 Bacitracin, 112 bacteriology gram negative, 57 gram positive, 57 biologics, 129–131 bleeding disorders, 50 blue lunulae (“warp”), 205 blue sclera (“gins poem”), 205 botox cosmetic, 37 buccal nerve, 14 carcinoma, basal cell, AJCC staging for, 94 carcinoma, cutaneous squamous cell AJCC staging for, 94 histologic grading of, 95 231 © Cambridge University Press www.cambridge.org Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information 232 Cephalexin (cephalosporin), 107–108 cervical nerve, 15 Chanarin-Dorfman syndrome (“idle PM”), 205 chemical peels deep, 36 medium, 36 superficial, 36 chemotherapy-induced hyperpigmentation, 206 CHILD syndrome, 206 chlorhexidine (HibiclensTM ), 30 chloroquine (Aralen), 127 chromoblastomycosis, 206 Churg-Strauss syndrome (“beansap”), 206–207 Ciprofloxacin (quinolone), 108 Clindamycin, 110–111 closure time-PFA-100 (platelet function assay), 48 coagulation cascade, 45 Colchicine, 139 collagen, 148–149 chromosome, 148–149 disease, 148–149 tissue distribution, 148–149 type, 148–149 complement system, 67 Conradi-Hunermann syndrome (“Conradi”), 207 corticosteroid potency, 136 intermediate, 136 long-acting, 136 short acting, 136 Cowden’s syndrome (“got tuba”), 207 CPY 2C9 inducers and inhibitors, 208–209 CPY 2D6 inducers and inhibitors, 209 © Cambridge University Press Index cranial nerves, 4–6 abducens (VI), 5 facial (VII), 5 glossopharyngeal (IX), 5–6 hypoglossal (XII), 6 oculomotor (III), 4 olfactory (I), 4 optic (II), 4 spinal accessory (XI), 6 trigeminal (V), 5 trochlear (IV), 4 vagal ((X), 6 vestibulocochlear (VIII), 5 CREST syndrome, 207 cutaneous leishmaniasis, 163 cutaneous T-cell lymphomas (CTCL), 96 cyclophosphamide (Cytoxan), 125 cyclosporine (Neoral), 123 CYP 1A2 inducers and inhibitors, 208 CYP 3A4 inducers and inhibitors, 209 cytochrome P-450 inducers (general), 208 cytochrome P-450 inhibitors (general), 208 cytotoxic agents, 125–126 Dapsone, 121 dermatology lists, 205, 226 dermatology mnemonics, 205, 226 dermatomes, 6–7 dermatopathology, “bodies” in, 223 dermis big blue balls in, 223 busy, 224 Dicloxacillin (β-lactamase resistant penicillin), 107 diffuse cutaneous leishmaniasis, 163 www.cambridge.org Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information Index disease, dermatologic antigen, 152–153 disease, 152–153 size (kD), 152–153 diseases, etiology of, 164–173 DNA viruses, 59 Doxycycline (tetracycline), 105 drugs, miscellaneous, 139–141 dyskeratosis congenita (“plans”), 210 ectothrix infections, 211–212 efaluzimab (Raptiva®), 130 electrosurgery biterminal, 29 electrocautery, 29 monoterminal, 29 endothrix infections, 212 eosinophilic spongiosis (“See a chip”), 224 epidermolysis bullosa, 86 dermolytic or dystrophic, 86–87 intraepidermal, 86 junctional, 86 erythema infectiosum (Fifth’s disease), 77 Erythromycin (macrolide), 106 etanercept (Enbrel®), 131 etiologies. See diseases, etiology of external carotid artery, 16 facial nerve (CN VII), 5, 14–15 Famciclovir, 118 Finasteride, 138 Fluconazole, 114–115 fluorescent dermatophytes, 212 focal dermal hypoplasia (Goltz)(“focal”), 212 glossopharyngeal nerve (CN IX), 5–6 © Cambridge University Press 233 green birefringence with polarized light, 212 grenz zone, 224 Griseofulvin, 115–116 hand-foot-mouth disease, 77 head and neck anterior cervical triangle, 18 carotid subdivision of, 19 muscular subdivision of, 19 submandibular subdivision of, 18 submental subdivision of, 18 neck triangles, 20 posterior cervical triangle, 20 hemostasis and diagnostics, 47–48 Henoch-Schönlein purpura (“hap”), 213 Hermansky-Pudlak syndrome (“pudlak”), 213 hexachlorophene (pHisoHexTM ), 30 histochemical staining, 154–155 purpose, 154–155 stain, 154–155 HLA associations, 213 hormone antagonists, 138 Finasteride, 138 Spironolactone, 138 HPV types, 61 diseases, 61 hydroxychloroquine (Plaquenil), 127 hypoglossal nerve (CN XII), 6 immunohistochemical staining, 156 epidermal, 156 hemapoietic, 156–157 mesenchymal, 156 miscellaneous, 157 neuroectodermal, 156 immunology, 66 www.cambridge.org Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information 234 immunomodulators. See systemic immunomodulators infliximab (Remicade®), 131 internal carotid artery, 16 internal maxillary artery, 16 intraepidermal eosinophilic vesicles, 224 intravenous immunoglobulin (IVIG), 101 iodine/iodophores (Betadine), 30 isopropyl alcohol (70%), 30 Itraconazole (triazole), 113–114 Ivermectin, 139 Kawasaki disease (mucocutaneous lymph node syndrome) (“fresca”), 78, 213 keratins in disease, 150–151 location, 150 type I, 150 type II, 150 Ketoconazole, 114 LAMB syndrome, 213 lasers and light infrared, 53 terminology, 53 ultraviolet, 53 uv spectrum wavelengths, 54 visible, 53 leishmaniasis, 163 uncommon forms of, 163 LEOPARD syndrome, 214 Levofloxacin (quinolone), 108–109 lichenoid reactions, drug-induced, 210 lidocaine toxicity, 42 linear IgA dermatosis, drug-induced, 211 lists. See dermatology lists © Cambridge University Press Index liver biopsies (Roenigk classification), 120 local anesthesia alternatives, 41 contraindications, 41 dosing calculations, 40 with epinephrine, 39 without epinephrine, 39 injectable, 40 lupus erythematosus, diagnostic criteria (“champions nd”), 214 mandibular nerve (CNV3), 12–13, 14 auriculotemporal branch of, 12 buccal branch of, 12 inferior alveolar branch of, 13 mast cell degranulators (nonimmunologic)(“prom”), 215 mastocytosis types (“mast”), 215 maxillary nerve (CN V2), 11 infraorbital branch of, 11 zygomaticofacial branch of, 11 zygomaticotemporal branch of, 11 melanoma AJCC staging for cutaneous, 91 AJCC-TNM classification, 89–90 Clark’s and Breslow staging of, 93 malignant, 92 5 year survival rates for, 92 surgical management for, 92 Methotrexate, 119 microbiology and immunology, 57–67 complement system, 67 DNA viruses, 59 HPV types, 61 diseases, 61 immunology, 66 www.cambridge.org Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information Index mycobacteria classification, 58 RNA viruses, 60 smallpox major criteria of, 62 minor criteria of, 62 vaccination complications, 63 vaccination timeline for, 62 verrucae, candida antigen therapy for, 64 Minocycline (tetracycline), 105 mnemonics. See dermatology mnemonics mucocutaneous leishmaniasis, 163 Muir-Torre syndrome (“sank”), 215 Mupirocin (Bactroban), 112 mycobacteria classification, 58 mycophenolate mofetil (Cellcept), 126 nail terminology, 74–75 NAME syndrome, 215 needles curvature of, 28 ethicon of, 28 length of, 28 syneture of, 28 type of, 28 Neomycin, 112 Netherton syndrome, 215 neurology, 7 Nicotinamide, 139–140 non-inflammatory subepidermal blister, 225 occipital artery, 16 occlusive wound dressings alginates, 33 film, 32 foam, 32 hydroactive, 33–34 hydrocolloid, 31–32 hydrofiber, 34 © Cambridge University Press 235 hydrogel, 31 zinc paste bandages, 34 oculomotor exam CN III, Inferior division, 8 CN III, Superior division, 8 CN IV, 8 CN VI, 8 oculomotor nerve (CN III), 4 olfactory nerve (CN I), 4 operative note, 3–4 opthalmic artery, 16 opthalmic nerve (CN V1), 11 frontalis (supraorbital) branch of, 11 frontalis (supratrochlear) branch of, 11 lacrimal branch of, 11 nasociliary (anterior ethmoidal external nasal) branch of, 11 nasociliary (infratrochlear) branch of, 11 nasociliary (posterior ethmoidal) branch of, 11 optic nerve (CN II), 4 pachyonychia congenita, 216 painful dermal tumors (“bengal”), 216 panniculitides, lobular, 159 with vasculitis, 159 without vasculitis, 159–160 panniculitides, septal, 158 with vasculitis, 158 without vasculitis, 158 paraneoplastic pemphigus, 153 parasitized histiocytes, 225 partial thromboplastin time (PTT; activated PTT; APTT), 47 patchy dermal lymphocytic infiltrates (“5 Ls”), 225 pediatric dermatology, 76–79 www.cambridge.org Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information 236 perforating disorders (“kerrp”), 216 permethrin (Elimite), 140 pigmentation, drug-induced, 211 POEMS syndrome, 216 Polymyxin B, 112 porphyrias, 83 laboratory evaluation for, 84 posterior auricular artery, 16 pregnancy. See Varicella Zoster Virus prothrombin time (PT/INR), 47 pseudocarcinomatous hyperplasia, 226 puritus without skin rash (“herb mend”), 216–217 PUVA therapy, 142 quinacrine (Atabrine), 127–128 Refsum’s syndrome (phytanic acid oxidase deficiency)(“crip”), 217 Rifampin, 110 Riley-Day syndrome (“didi data”), 217 RNA viruses, 60 Rombo syndrome (“bath mc”), 217 roseola, 76 rubella (German measles), 76 rubeola (measles), 76 sarcoid syndromes, 218 saturated solution of potassium iodide (SSKI), 140 scalp layers (“scalp”), 214 scarlet fever, 78 Schnitzler’s syndrome, 218 SCORTEN system, 102 mortality rate, 102 risk factors, 102 signs, dermatologic, 161–162 © Cambridge University Press Index Sjögren-Larsson syndrome (“Larson”), 218 skin grafts full thickness (FTSG), 35 split thickness (STSG), 35 terminology, 35 types of, 35 skin lesion terminology primary skin lesions, 73 secondary skin lesions, 73 skin, structure/function of, 88 anchoring filaments, 88 lamina densa, 88 lamina lucida, 88 plasma membrane, 88 sublamina densa, 88 skin types, 143 UVA/UVB based on, 143 smallpox major criteria of, 62 minor criteria of, 62 vaccination complications, 63 vaccination timeline for, 62 spinal accessory nerve (CN XI), 6 Spironolactone, 138 staining. See histochemical staining; immunohistochemical staining steroidogenesis, 147 subepidermal bullae with neutrophils (“plaid”), 226 superficial temporal artery, 16 sutures absorbable, 27 absorption (days), 27 non-absorbable, 27 Sweet’s syndrome, drug-induced, 211 syndromes, 179–201 systemic antibacterials, 105–111 systemic antifungals, 113–116 www.cambridge.org Cambridge University Press 0521618134 - Pocket Guide for Cutaneous Medicine and Surgery Joshua E. Lane Index More information Index systemic antivirals, 117–118 systemic cutaneous lupus erythematosus, drug-induced, 210 systemic immunomodulators, 122–123 systemic lupus erythematosus, 80 laboratory test for, 81 systemic lupus erythematosus, drug-induced, 210 systemic retinoids, 103 acitretin (Soriatane), 103–104 isotretinoin (Accutane), 103 temporal nerve, 14 Terbinafine (allylamine), 113 Tetracycline (tetracycline), 105–106 Thalidomide, 141 topical anesthesia, 38 topical antimicrobials, 112 topical corticosteroids, 132–135 high potency group (II), 132 low potency group (VI), 134 low potency group (VII), 135 mid potency group (IV), 133 mid potency group (V), 133–134 potent group (III), 132–133 super-high potency group (I), 132 toxic epidermal necrolysis (TEN) protocol, 97–98 triclosan, 30 © Cambridge University Press 237 trigeminal nerve (CN V), 5, 11–13 Trimethoprim-Sulfamethoxazole (TMP:SMX = 1:5), 109 trochlear nerve (CN IV), 4 vagal nerve (CN X), 6 Valacyclovir, 117–118 Varicella Zoster Virus (VZV), 77 pregnancy and, 79 vasculitis, 158, 159 verrucae, candida antigen therapy for, 64 vestibulocochlear nerve (CN VIII), 5 visceral leishmaniasis, 163 vitamins (“the rich never pay cash”), 219 Wegener’s granulomatosis (“rough”), 218 Wiskott-Aldrich (XLR inheritance)(“tie”), 219 x-linked dominant diseases, 178 disease, 178 gene, 178 x-linked recessive diseases, 178 disease, 178 gene, 178 zygomatic nerve, 14 www.cambridge.org